Abstract:The connection of two or more proteins with different binding specificities or activities can lead to unique and powerful systems with significant potential in therapeutic applications, particularly oncology. While a plethora of active bifunctional proteins have been produced by fusion, this approach is not always viable, since modification of the N- or C- terminus can compromise the proteins’ bioactivities, with complications during folding and processing often being observed. Chemical cross-linking can offer a more versatile strategy towards the synthesis of protein-protein conjugates. However, current state-of-the-art approaches are either not selective, yielding heterogeneous mixtures or require mutations with natural or unnatural amino acids, which are often associated with low expression yields and limited applicability towards all protein systems. Recently, a bis-dibromomaleimide cross-linking reagent was used to create a bispecific scFv-Fab antibody in a site-specific manner, by targeting and bridging disulfide bonds. In this work, the application of these cross-linking reagents was extended into the conjugation of proteins containing different reactive handles, as well as sterically hindered conjugation sites. Diiodo-maleimides were shown to offer the ideal properties of rapid bioconjugation and importantly, reduced hydrolysis, which was identified as a significant factor affecting the conjugation efficiency. The optimized linkers were exploited to link human serum albumin to antibody fragments (scFv and Fab) as a prospective half-life extension platform, with retention of antigen binding and robust serum stability. The linker design was also extended to incorporate a third point of attachment for another biomolecule. An anti-CEA scFv homotrimer was formed, by disulfide bridging, which was shown to infer a combination of greater antigen avidity and increased in vivo half-life. Finally, with the view to developing a Bispecific T-cell Engager (BiTE) construct that could lead to more efficient cell-killing, an anti-CEA/ anti-CD3 scFv heterotrimer of increased avidity towards CD3 antigen was developed, showing the potential of this strategy for the construction of a diverse range of bioconjugates. The last part of this thesis describes investigations towards the development of a new methodology that selectively modifies specific lysine residues, via acyl transfer from the disulfide bond of Fab antibody fragment. This approach is expected to complement disulfide bridging as a strategy for selective modification, but also be advantageous for systems where this could result in detrimental changes to the antibody structure, offering a highly promising platform for bioconjugation.

Design and construction of chimeric linker library with controllable flexibilities for precision protein engineering

Construction of a linker library with widely controllable flexibility for fusion protein design

A study on the effects of linker flexibility on acid phosphatase PhoC-GFP fusion protein using a novel linker library.

Design of helical linkers for fusion proteins and protein-based nanostructures

iFLinkC: an iterative functional linker cloning strategy for the combinatorial assembly and recombination of linker peptides with functional domains

Binding to Semiflexible Polymers: a Novel Method to Control the Structures of Small Numbers of Building Blocks

Effect of peptide linker length and composition on immobilization and catalysis of leucine zipper‐enzyme fusion proteins

Linker engineering for fusion protein construction: Improvement and characterization of a GLP-1 fusion protein.

Chimeric single α-helical domains as rigid fusion protein connections for protein nanotechnology and structural biology

Bifunctional Enhancement of a Β-Glucanase-xylanase Fusion Enzyme by Optimization of Peptide Linkers

LinkerNet: Fragment Poses and Linker Co-Design with 3D Equivariant Diffusion

A One-Pot Photocatalytic Triazole-Based Linkerology for PROTACs

Molecular Modeling and Affinity Determination of Scfv Antibody: Proper Linker Peptide Enhances Its Activity

An open source in silico workflow to assist in the design of fusion proteins

Chimeric 14-3-3 proteins for unraveling interactions with intrinsically disordered partners

Construction of homologous branched oligomer megamolecules based on linker-directed protein assembly

Characteristic roadmap of linker governs the rational design of PROTACs

New Strategies for Cysteine Bioconjugation and Protein Cross-Linking

Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors

Nature-inspired protein ligation and its applications

Computation, Synthesis and NMR Investigations of PROTAC Linker Conformation, Chamaleonicity and their Impacts on the Mode of Action